1. Home
  2. OPK

as 07-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

Founded: N/A Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: 878.2M IPO Year: 1995
Target Price: $3.17 AVG Volume (30 days): 2.8M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.35 EPS Growth: N/A
52 Week Low/High: $0.85 - $2.22 Next Earning Date: 08-01-2024
Revenue: $799,603,000 Revenue Growth: -12.38%
Revenue Growth (this year): -16.84% Revenue Growth (next year): 4.93%

OPK Daily Stock ML Predictions

Stock Insider Trading Activity of OPKO Health Inc. (OPK)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
OPKO HEALTH, INC. OPK 10% Owner Jul 5 '24 Sell $28.24 36,118 $1,020,015.66 3,433,403 SEC Form 4
OPKO HEALTH, INC. OPK 10% Owner Jul 1 '24 Sell $28.23 14,082 $397,491.21 3,469,521 SEC Form 4
OPKO HEALTH, INC. OPK 10% Owner Jul 1 '24 Sell $29.12 25,000 $728,095.00 3,483,603 SEC Form 4
OPKO HEALTH, INC. OPK 10% Owner Jul 1 '24 Sell $26.63 50,000 $1,331,700.00 3,508,603 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman May 23 '24 Buy $1.27 99,230 $125,962.56 211,231,452 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman May 23 '24 Buy $1.27 770 $974.05 211,232,222 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman May 17 '24 Buy $1.29 163,997 $211,195.34 211,132,222 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Mar 18 '24 Buy $0.87 500,000 $437,100.00 210,968,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Mar 14 '24 Buy $0.89 500,000 $444,300.00 210,468,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Mar 13 '24 Buy $0.93 500,000 $463,750.00 209,968,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Mar 12 '24 Buy $0.93 600,000 $559,380.00 209,468,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Feb 28 '24 Buy $0.99 500,000 $496,150.00 208,868,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Feb 21 '24 Buy $0.99 1,000,000 $991,700.00 208,368,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Feb 7 '24 Buy $0.98 1,500,000 $1,462,800.00 207,368,225 SEC Form 4
KRASNO RICHARD M OPK Director Jan 29 '24 Buy $0.99 30,000 $29,838.00 103,333 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Jan 19 '24 Buy $0.98 500,000 $488,650.00 205,868,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Jan 18 '24 Buy $0.97 400,000 $386,200.00 205,368,225 SEC Form 4
HSIAO JANE PH D OPK Vice Chairman & CTO Jan 17 '24 Buy $0.95 150,000 $142,500.00 27,999,880 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Jan 16 '24 Buy $0.95 1,000,000 $954,300.00 204,968,225 SEC Form 4
FROST PHILLIP MD ET AL OPK CEO & Chairman Jan 11 '24 Buy $0.94 511,531 $480,378.76 203,968,225 SEC Form 4
Nabel Gary J. OPK Chief Innovation Officer Jan 8 '24 Buy $0.93 108,695 $100,542.88 351,442 SEC Form 4
Nabel Gary J. OPK Chief Innovation Officer Jan 8 '24 Buy $0.92 500 $458.90 500 SEC Form 4
Nabel Gary J. OPK Chief Innovation Officer Jan 8 '24 Buy $0.93 106,989 $99,424.88 107,489 SEC Form 4
Zerhouni Elias A. OPK Vice Chairman and President Jan 5 '24 Buy $0.87 17,000 $14,790.00 19,794,514 SEC Form 4
Zerhouni Elias A. OPK Vice Chairman and President Jan 5 '24 Buy $0.91 33,300 $30,303.00 19,827,814 SEC Form 4

Share on Social Networks: